Susquehanna International Group
FSTX

Susquehanna International Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Susquehanna International Group’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,066
Closed -$348K – 14064
2022
Q4 		$348K Sell
55,066
-51,670
-48% -$286K ﹤0.01% 8739
2022
Q3 		$546K Sell
106,736
-41,198
-28% -$259K ﹤0.01% 8253
2022
Q2 		$926K Buy
+147,934
New +$498K ﹤0.01% 6721
2022
Q1 		– Sell
-14,251
Closed -$72K – 14376
2021
Q4 		$72K Buy
+14,251
New +$85.9K ﹤0.01% 12361
2019
Q3 		– Sell
-6,171
Closed -$91K – 11044
2019
Q2 		$91K Buy
+6,171
New +$165K ﹤0.01% 9647
2018
Q3 		– Sell
-3,870
Closed -$183K – 10530
2018
Q2 		$183K Sell
3,870
-5,649
-59% -$313K ﹤0.01% 8696
2018
Q1 		$586K Buy
+9,519
New +$502K ﹤0.01% 6305
2017
Q1 		– Sell
-27,411
Closed -$876K – 10267
2016
Q4 		$876K Buy
+27,411
New +$1M ﹤0.01% 5813

Susquehanna International Group's FSTX Position: Q1 2023 in Review

Susquehanna International Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 55,066 shares — an estimated $348K sold.

Susquehanna International Group first reported a position in FSTX in Q4 2016 and held it in 8 quarters. The position peaked at $926K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Susquehanna International Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 55,066 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $348K.
  • Susquehanna International Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2016 and held it in 8 quarters.
  • Susquehanna International Group's F-star Therapeutics, Inc. Common Stock position peaked at $926K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.